Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

CUSIP: 92511W108

Q3 2025 13F Holders as of 30 Sep 2025

Security identity 2 facts
Security type / class
Equity / Common Stock, $0.0001 par value
Shares outstanding
92,448,158
Holder snapshot 7 facts
Total 13F shares
568
Share change
-24,694,023
Total reported value
$301
Reported price per share
$0.53
Number of holders
1
Value change
-$13,341,086
Number of sells
51

Security key

92511W108

Report period

Q3 2025

Institutions

1

Top holders

1

VRCA full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Verrica Pharmaceuticals Inc. SEC filings Verrica Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Caligan Partners LP
13D/G signal
Caligan Partners LP
Evidence rows
15
Latest as of
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: Caligan Partners LP Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Caligan Partners LP
13D/G 13F
Company
13D/G 13F
10%
$7,769,760
15,856,653 shares
 $0 31 Dec 2024
ARMISTICE CAPITAL, LLC
13D/G 13F
Company
13D/G 13F
10%
$7,480,813
9,235,571 shares
 +$81,611 31 Mar 2025
PERCEPTIVE ADVISORS LLC
3/4/5 13D/G
10%+ Owner
3/4/5 13D/G
1.6%
from 13D/G
$51,398,078
7,099,182 shares
 — 27 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
2.3%
$1,149,205
2,168,310 shares
 — 30 Jun 2025
MARSHALL WACE, LLP
13F
Company
13F
1.4%
$65,696
123,953 shares
 — 30 Jun 2025
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
0.98%
$480,841
907,076 shares
 — 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
568
Rows available
1
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
52
Q3 2025 holders
1
Holder diff
-51
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .